Insider trades
George L. Sing, Director of Regeneron Pharmaceuticals REGN, has filed 0 purchases and 8 sales on the open market. The latest trade was on 01/02.
George L. Sing
Director
- First filing
- 23/01/05
- Trades
- 39 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- No record
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
REGN | Open-market sale | 24/02/26 | 24/02/28 | 1,000 sh2 trades | $992.50avg. | $992,500 | −3.7% |
REGN | Open-market sale | 24/02/22–24/02/23 | 24/02/26 | 3,500 sh4 trades | $967.86avg. | $3,387,500 | −11.7% |
REGN | Open-market sale | 24/02/08–24/02/09 | 24/02/12 | 1,000 sh2 trades | $950.00avg. | $950,000 | −3.7% |